{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:28:52Z","timestamp":1791167332996,"version":"4.1.0"},"reference-count":37,"publisher":"Rockefeller University Press","issue":"11","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1998,6,1]]},"abstract":"<jats:p>The efficacy of thalidomide (\u03b1-phthalimido-glutarimide) therapy in leprosy patients with erythema nodosum leprosum is thought to be due to inhibition of tumor necrosis factor \u03b1. In other diseases reported to respond to thalidomide, the mechanism of action of the drug is unclear. We show that thalidomide is a potent costimulator of primary human T cells in vitro, synergizing with stimulation via the T cell receptor complex to increase interleukin 2\u2013mediated T cell proliferation and interferon \u03b3 production. The costimulatory effect is greater on the CD8+ than the CD4+ T cell subset. The drug also increases the primary CD8+ cytotoxic T cell response induced by allogeneic dendritic cells in the absence of CD4+ T cells. Therefore, human T cell costimulation can be achieved pharmacologically with thalidomide, and preferentially in the CD8+ T cell subset.<\/jats:p>","DOI":"10.1084\/jem.187.11.1885","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"1885-1892","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":461,"title":["Thalidomide Costimulates Primary Human T Lymphocytes, Preferentially Inducing Proliferation, Cytokine Production, and Cytotoxic Responses in the CD8+ Subset"],"prefix":"10.1084","volume":"187","author":[{"given":"Patrick A.J.","family":"Haslett","sequence":"first","affiliation":[{"name":"From The Rockefeller University, New York 10021-6399"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Corral","sequence":"additional","affiliation":[{"name":"From The Rockefeller University, New York 10021-6399"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Albert","sequence":"additional","affiliation":[{"name":"From The Rockefeller University, New York 10021-6399"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilla","family":"Kaplan","sequence":"additional","affiliation":[{"name":"From The Rockefeller University, New York 10021-6399"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[1998,6,1]]},"reference":[{"key":"2023072507413533600_B1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin Pharmacol Ther"},{"key":"2023072507413533600_B2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"2023072507413533600_B3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor \u03b1 production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"2023072507413533600_B4","first-page":"26","article-title":"An internally controlled double-blind trial of thalidomide in severe erythema nodosum leprosum","volume":"42","author":"Waters","year":"1971","journal-title":"Lepr Rev"},{"key":"2023072507413533600_B5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection","volume":"336","author":"Jacobson","year":"1991","journal-title":"N Engl J Med"},{"key":"2023072507413533600_B6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/aid.1997.13.301","article-title":"A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers","volume":"13","author":"Alexander","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2023072507413533600_B7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0753-3322(89)90089-9","article-title":"Thalidomide for the therapy of chronic graft-versus-host disease following allogeneic bone marrow transplantation","volume":"43","author":"McCarthy","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"2023072507413533600_B8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"2023072507413533600_B9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.iy.07.040189.002305","article-title":"Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy","volume":"7","author":"Mueller","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"2023072507413533600_B10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1496399","article-title":"Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule","volume":"257","author":"Linsley","year":"1992","journal-title":"Science"},{"key":"2023072507413533600_B11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(96)00079-8","article-title":"Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood","volume":"196","author":"Bender","year":"1996","journal-title":"J Immunol Methods"},{"key":"2023072507413533600_B12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.171.4.1315","article-title":"Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells","volume":"171","author":"Young","year":"1990","journal-title":"J Exp Med"},{"key":"2023072507413533600_B13","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.140.10.3324","article-title":"Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells","volume":"140","author":"Jenkins","year":"1988","journal-title":"J Immunol"},{"key":"2023072507413533600_B14","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.135.5.2953","article-title":"Dissection of the functions of antigen-presenting cells in the induction of T cell activation","volume":"135","author":"Roska","year":"1985","journal-title":"J Immunol"},{"key":"2023072507413533600_B15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03401576","article-title":"Thalidomide treatment reduces tumor necrosis factor \u03b1 production and enhances weight gain in patients with pulmonary tuberculosis","volume":"1","author":"Tramontana","year":"1995","journal-title":"Mol Med"},{"key":"2023072507413533600_B16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0024-3205(94)90099-X","article-title":"Thalidomide and the immune response. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells","volume":"55","author":"Nogueira","year":"1994","journal-title":"Life Sci"},{"key":"2023072507413533600_B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Exp Immunol"},{"key":"2023072507413533600_B18","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.159.10.5157","article-title":"Inhibition of IL-12 production by thalidomide","volume":"159","author":"Moller","year":"1997","journal-title":"J Immunol"},{"key":"2023072507413533600_B19","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507413533600_B20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/2111308a0","article-title":"Effect of thalidomide on the graft versus host reaction","volume":"211","author":"Field","year":"1966","journal-title":"Nature"},{"key":"2023072507413533600_B21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00007890-198605000-00018","article-title":"Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model","volume":"41","author":"Vogelsang","year":"1986","journal-title":"Transplantation (Baltimore)"},{"key":"2023072507413533600_B22","first-page":"2658","article-title":"Thalidomide induction of bone marrow transplantation tolerance","volume":"19","author":"Vogelsang","year":"1987","journal-title":"Transplant Proc"},{"key":"2023072507413533600_B23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00007890-199111000-00029","article-title":"Immunosuppressive properties of thalidomide","volume":"52","author":"Keenan","year":"1991","journal-title":"Transplantation (Baltimore)"},{"key":"2023072507413533600_B24","first-page":"241","article-title":"The effects of two soluble thalidomide derivatives on lymphocyte stimulation","volume":"7","author":"Coulson","year":"1970","journal-title":"Clin Exp Immunol"},{"key":"2023072507413533600_B25","first-page":"978","article-title":"Does thalidomide affect IL-2 response and production?","volume":"23","author":"Fernandez","year":"1995","journal-title":"Exp Hematol"},{"key":"2023072507413533600_B26","first-page":"402","article-title":"Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers","volume":"17","author":"Chen","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"2023072507413533600_B27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0162-3109(95)00039-7","article-title":"Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative","volume":"31","author":"Shannon","year":"1995","journal-title":"Immunopharmacology"},{"key":"2023072507413533600_B28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0966-3274(96)80005-0","article-title":"Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro","volume":"4","author":"\u00d6straat","year":"1996","journal-title":"Transplant Immunol"},{"key":"2023072507413533600_B29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/aid.1997.13.1047","article-title":"The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus","volume":"13","author":"Haslett","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2023072507413533600_B30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.iy.10.040192.002321","article-title":"Stigma variations: observations on suppressor T cells and leprosy","volume":"10","author":"Bloom","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"2023072507413533600_B31","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.256.5060.1210","article-title":"Less mortality but more relapses in experimental allergic encephalomyelitis in CD8\u2212\/\u2212 mice","volume":"256","author":"Koh","year":"1992","journal-title":"Science"},{"key":"2023072507413533600_B32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(95)80066-2","article-title":"Human CD8+ T lymphocyte clones specific for T cell receptor V\u03b2 families expressed on autologous CD4+ T cells","volume":"2","author":"Ware","year":"1995","journal-title":"Immunity"},{"key":"2023072507413533600_B33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.1991.tb05756.x","article-title":"Human colonic intra-epithelial cells are suppressor cells","volume":"85","author":"Hoang","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2023072507413533600_B34","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI114832","article-title":"Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease","volume":"86","author":"Mayer","year":"1990","journal-title":"J Clin Invest"},{"key":"2023072507413533600_B35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/bmj.1.6166.792","article-title":"Treatment of ulcerative colitis with thalidomide","volume":"1","author":"Waters","year":"1979","journal-title":"Brit Med J"},{"key":"2023072507413533600_B36","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(05)64206-7","article-title":"Thalidomide in Crohn's disease","volume":"350","author":"Wettstein","year":"1997","journal-title":"Lancet"},{"key":"2023072507413533600_B37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(97)80083-9","article-title":"Randomised controlled trial of CDP571 antibody to tumour necrosis factor-\u03b1 in Crohn's disease","volume":"349","author":"Stack","year":"1997","journal-title":"Lancet"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/187\/11\/1885\/1686160\/98-0144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/187\/11\/1885\/1686160\/98-0144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T08:26:34Z","timestamp":1690273594000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/187\/11\/1885\/7381\/Thalidomide-Costimulates-Primary-Human-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6,1]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,6,1]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.187.11.1885","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6,1]]}}}